121
Views
27
CrossRef citations to date
0
Altmetric
Brief report

Dynamics of Cellular HIV-1 DNA Levels Over 144 Weeks of Darunavir/Ritonavir Monotherapy Versus Triple Therapy in the MONET Trial

, , , , , , , & show all
Pages 45-50 | Published online: 06 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Thierry Prazuck, David Zucman, Véronique Avettand-Fènoël, Elodie Ducasse, Dominique Bornarel, Catherine Mille, Christine Rouzioux & Laurent Hocqueloux. (2013) Long-Term HIV-1 Virologic Control in Patients on a Dual NRTI Regimen. HIV Clinical Trials 14:3, pages 120-126.
Read now

Articles from other publishers (26)

Ilaria Vicenti, Filippo Dragoni, Alessia Giannini, Anna Casabianca, Francesca Lombardi, Laura Di Sante, Ombretta Turriziani, Sara Racca, Stefania Paolucci, Alessia Lai, Isabella Bon, Isabella Abbate, Gabriella Rozera, Simone Belmonti, Rossana Scutari, Claudia Alteri, Francesco Saladini, Maurizio Zazzi, Chiara Orlandi, Mauro Magnani, Simona Di Giambenedetto, Roberta Longo, Stefano Menzo, Daniele Di Carlo, Laura Mazzuti, Anna Ardemagni, Massimo Clementi, Fausto Baldanti, Federica Giardina, Annalisa Bergna, Claudia Balotta, Alessia Bertoldi, Maria Rosaria Capobianchi, Francesca Ceccherini-Silberstein, Maria Antonello, Carlo Federico Perno & Massimo Andreoni. (2022) External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy. Scientific Reports 12:1.
Crossref
Simone Belmonti, Simona Di Giambenedetto & Francesca Lombardi. (2021) Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice. Diagnostics 12:1, pages 39.
Crossref
Valeria Cento & Carlo Federico Perno. (2021) Dolutegravir Plus Lamivudine Two-Drug Regimen: Safety, Efficacy and Diagnostic Considerations for Its Use in Real-Life Clinical Practice—A Refined Approach in the COVID-19 Era. Diagnostics 11:5, pages 809.
Crossref
Sofie Rutsaert, Ward De Spiegelaere, Laura De Clercq & Linos Vandekerckhove. (2019) Evaluation of HIV-1 reservoir levels as possible markers for virological failure during boosted darunavir monotherapy. Journal of Antimicrobial Chemotherapy 74:10, pages 3030-3034.
Crossref
Sidonie Lambert-Niclot, Maxime Grude, Jean-Luc Meynard, Anne-Geneviève Marcelin, Marc-Antoine Valantin, Philippe Flandre, Jacques Izopet, Laetitia Moinot, Vincent Bouteloup, Vincent Calvez, Christine Katlama, Pierre-Marie Girard & Laurence Morand-Joubert. (2018) Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clinical Infectious Diseases 67:12, pages 1883-1889.
Crossref
Francesca Ceccherini-Silberstein, Alessandro Cozzi Lepri, Claudia Alteri, Esther Merlini, Matteo Surdo, Giulia Marchetti, Maria Rosaria Capobianchi, Andrea De Luca, Nicola Gianotti, Pierluigi Viale, Massimo Andreoni, Andrea Antinori, Carlo Federico Perno, Antonella d’Arminio Monforte, A d’Arminio Monforte, A Antinori, A Castagna, F Castelli, R Cauda, G Di Perri, M Galli, R Iardino, G Ippolito, A Lazzarin, G C Marchetti, C F Perno, G Rezza, F von Schloesser, P Viale, A d’Arminio Monforte, A Antinori, A Castagna, F Ceccherini-Silberstein, A Cozzi-Lepri, E Girardi, S Lo Caputo, C Mussini, M Puoti, C F Perno, M Andreoni, A Ammassari, A Antinori, C Balotta, A Bandera, P Bonfanti, S Bonora, M Borderi, A Calcagno, L Calza, M R Capobianchi, A Castagna, F Ceccherini-Silberstein, A Cingolani, P Cinque, A Cozzi-Lepri, A d’Arminio Monforte, A De Luca, A Di Biagio, E Girardi, N Gianotti, A Gori, G Guaraldi, G Lapadula, M Lichtner, S Lo Caputo, G Madeddu, F Maggiolo, G Marchetti, S Marcotullio, L Monno, C Mussini, S Nozza, M Puoti, E Quiros Roldan, R Rossotti, S Rusconi, M M Santoro, A Saracino, M Zaccarelli, A Cozzi-Lepri, I Fanti, L Galli, P Lorenzini, A Rodano, M Shanyinde, A Tavelli, F Carletti, S Carrara, A Di Caro, S Graziano, F Petrone, G Prota, S Quartu, S Truffa, A Giacometti, A Costantini, V Barocci, G Angarano, L Monno, C Santoro, F Maggiolo, C Suardi, P Viale, V Donati, G Verucchi, F Castelli, C Minardi, E Quiros Roldan, T Quirino, C Abeli, P E Manconi, P Piano, B Cacopardo, B Celesia, J Vecchiet, K Falasca, L Sighinolfi, D Segala, P Blanc, F Vichi, G Cassola, C Viscoli, A Alessandrini, N Bobbio, G Mazzarello, C Mastroianni, I Pozzetto, P Bonfanti, C Molteni, A Chiodera, P Milini, G Nunnari, G Pellicanò, A d’Arminio Monforte, M Galli, A Lazzarin, G Rizzardini, M Puoti, A Castagna, G Marchetti, M C Moioli, R Piolini, A L Ridolfo, S Salpietro, C Tincati, C Mussini, C Puzzolante, A Gori, G Lapadula, A Chirianni, G Borgia, V Esposito, R Orlando, G Bonadies, F Di Martino, I Gentile, L Maddaloni, A M Cattelan, S Marinello, A Cascio, C Colomba, F Baldelli, E Schiaroli, G Parruti, F Sozio, G Magnani, M A Ursitti, M Andreoni, A Antinori, R Acinapura, G Baldin, M Capozzi, R Cauda, S Cicalini, A Cingolani, A Cristaudo, L Fontanelli Sulekova, G Iaiani, A Latini, I Mastrorosa, M M Plazzi, S Savinelli, A Vergori, V Vullo, M Cecchetto, F Viviani, G Madeddu, P Bagella, A De Luca, B Rossetti, A Franco, R Fontana Del Vecchio, D Francisci, C Di Giuli, P Caramello, G Di Perri, S Bonora, G C Orofino, M Sciandra, M Bassetti, A Londero, G Pellizzer, V Manfrin, G Starnini & A Ialungo. (2018) Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART. Journal of Antimicrobial Chemotherapy.
Crossref
Virginie Mortier, Els Demecheleer, Delfien Staelens, Marlies Schauvliege, Kenny Dauwe, Sylvie Dinakis, Laura Hebberecht, Leen Vancoillie & Chris Verhofstede. (2018) Quantification of total HIV-1 DNA in buffy coat cells, feasibility and potential added value for clinical follow-up of HIV-1 infected patients on ART. Journal of Clinical Virology 106, pages 58-63.
Crossref
Kobus J Bosman, Annemarie MJ Wensing, Aster E Pijning, Wilco J van Snippenberg, Petra M van Ham, Dorien MC de Jong, Andy IM Hoepelman & Monique Nijhuis. (2018) Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms. Journal of the International AIDS Society 21:9, pages e25185.
Crossref
Maria C Puertas, Elisabet Gómez-Mora, José R Santos, José Moltó, Víctor Urrea, Sara Morón-López, Agueda Hernández-Rodríguez, Silvia Marfil, Marta Martínez-Bonet, Lurdes Matas, Mª Angeles Muñoz-Fernández, Bonaventura Clotet, Julià Blanco & Javier Martinez-Picado. (2018) Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs. Journal of Antimicrobial Chemotherapy 73:7, pages 1940-1948.
Crossref
Kamelia R. Stanoeva, André König, Asami Fukuda, Yoko Kawanami, Takeo Kuwata, Yorifumi Satou & Shuzo Matsushita. (2018) Total HIV-1 DNA Dynamics and Influencing Factors in Long-Term ART-Treated Japanese Adults: A Retrospective Longitudinal Analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes 78:2, pages 239-247.
Crossref
Francesca Lombardi, Simone Belmonti, Lucrezia Rapone, Alberto Borghetti, Arturo Ciccullo, Roberta Gagliardini, Gianmaria Baldin, Francesca Montagnani, Davide Moschese, Arianna Emiliozzi, Barbara Rossetti, Andrea De Luca & Simona Di Giambenedetto. (2018) HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART. Journal of Clinical Virology 103, pages 57-62.
Crossref
Alessandra Ruggiero, Alessandro Cozzi-Lepri, Apostolos Beloukas, Douglas Richman, Saye Khoo, Andrew Phillips & Anna Maria Geretti. (2018) Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy. Open Forum Infectious Diseases 5:2.
Crossref
Gábor Artúr Dunay, Anastasia Solomatina, Silke Kummer, Anja Hüfner, Julia Katharina Bialek, Johanna Maria Eberhard, Eva Tolosa, Joachim Hauber & Julian Schulze zur Wiesch. (2017) Assessment of the HIV-1 reservoir in CD4+ regulatory T cells by a Droplet Digital PCR based approach. Virus Research 240, pages 107-111.
Crossref
Francesca Lombardi, Simone Belmonti, Eugenia Quiros-Roldan, Alessandra Latini, Antonella Castagna, Gabriella D’Ettorre, Roberta Gagliardini, Massimiliano Fabbiani, Roberto Cauda, Andrea De Luca & Simona Di Giambenedetto. (2017) Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial. Journal of Antimicrobial Chemotherapy 72:7, pages 2055-2059.
Crossref
Christine Katlama, Jade Ghosn & Robert L. Murphy. (2017) Individualized antiretroviral therapeutic approaches. AIDS 31:8, pages 1065-1071.
Crossref
Nicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, Antonella Castagna, Andrea De Luca, Benedetto Maurizio Celesia, Massimo Galli, Cristina Mussini, Carmela Pinnetti, Vincenzo Spagnuolo, Antonella d’Arminio Monforte, Francesca Ceccherini-Silberstein & Massimo Andreoni. (2017) Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients. PLOS ONE 12:2, pages e0171611.
Crossref
Véronique Avettand-Fènoël, Laurent Hocqueloux, Jade Ghosn, Antoine Cheret, Pierre Frange, Adeline Melard, Jean-Paul Viard & Christine Rouzioux. (2016) Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications. Clinical Microbiology Reviews 29:4, pages 859-880.
Crossref
Nicholas I Paton, Wolfgang Stöhr, Lars Oddershede, Alejandro Arenas-Pinto, Simon Walker, Mark Sculpher & David T Dunn. (2016) The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection. Health Technology Assessment 20:21, pages 1-158.
Crossref
. (2015) Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos con infección por el virus de la inmunodeficiencia humana (Actualización enero 2015). Enfermedades Infecciosas y Microbiología Clínica 33:8, pages 543.e1-543.e43.
Crossref
Alessandra Ruggiero, Ward De Spiegelaere, Alessandro Cozzi-Lepri, Maja Kiselinova, Georgios Pollakis, Apostolos Beloukas, Linos Vandekerckhove, Matthew Strain, Douglas Richman, Andrew Phillips, Anna Maria Geretti, Paola Vitiello, Nicola Mackie, Jonathan Ainsworth, Anele Waters, Frank Post, Simon Edwards & Julie Fox. (2015) During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ. EBioMedicine 2:9, pages 1153-1159.
Crossref
Lise Cuzin, Pascal Pugliese, Karine Sauné, Clotilde Allavena, Jade Ghosn, Jacqueline Cottalorda, Audrey Rodallec, Marie Laure Chaix, Samira Fafi-Kremer, Cathia Soulié, Marlène Ouka, Charlotte Charpentier, Laurence Bocket, Audrey Mirand & Marguerite Guiguet. (2015) Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy. AIDS 29:13, pages 1665-1671.
Crossref
S.G. Parisi, L. Sarmati, S. Andreis, R. Scaggiante, M. Cruciani, R. Ferretto, V. Manfrin, M. Basso, M. Andreoni, C. Mengoli & G. Palù. (2015) Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy. Clinical Microbiology and Infection 21:3, pages 288.e5-288.e7.
Crossref
N. Gianotti, F. Canducci, L. Galli, F. Cossarini, S. Salpietro, A. Poli, S. Nozza, V. Spagnuolo, M. Clementi, M. Sampaolo, E.R. Ceresola, S. Racca, A. Lazzarin & A. Castagna. (2015) HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients. Clinical Microbiology and Infection 21:1, pages 103.e7-103.e10.
Crossref
Antonella Castagna, Vincenzo Spagnuolo, Laura Galli, Concetta Vinci, Silvia Nozza, Elisabetta Carini, Antonella D’Arminio Monforte, Francesco Montella, Andrea Antinori, Antonio Di Biagio, Stefano Rusconi & Adriano Lazzarin. (2014) Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression. AIDS 28:15, pages 2269-2279.
Crossref
. (2014) Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualización enero 2014). Enfermedades Infecciosas y Microbiología Clínica 32:7, pages 446.e1-446.e42.
Crossref
Pedro Miguel Salcedo Gómez, Masayuki Amano, Sofiya Yashchuk, Akira Mizuno, Debananda Das, Arun K. Ghosh & Hiroaki Mitsuya. (2013) GRL-04810 and GRL-05010, Difluoride-Containing Nonpeptidic HIV-1 Protease Inhibitors (PIs) That Inhibit the Replication of Multi-PI-Resistant HIV-1 In Vitro and Possess Favorable Lipophilicity That May Allow Blood-Brain Barrier Penetration . Antimicrobial Agents and Chemotherapy 57:12, pages 6110-6121.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.